Trevo NXT ProVue Retriever

FDA 510(k) K223305 · Stryker Neurovascular

Substantially Equivalent

510(k) numberK223305

Submission

Device name
Trevo NXT ProVue Retriever
Applicant
Stryker Neurovascular
Fremont, CA, US
Received
October 27, 2022
Decision date
March 29, 2023
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
POL – Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment
Device class
Class II (moderate risk)
Regulation
21 CFR 882.5600
Specialty
Neurology

A neurovascular mechanical thrombectomy device for acute ischemic stroke treatment is a prescription device used in the treatment of acute ischemic stroke to improve clinical outcomes. The device is delivered into the neurovasculature with an endovascular approach, mechanically removes thrombus from the body, and restores blood flow in the neurovasculature.

Other 510(k)s with product code POL

510(k)DeviceApplicantDecision
K242676pRESET Delta Thrombectomy Device and pRESET Delta LITE Thrombectomy DevicePOL · Special Phenox Limited02/28/2025SE
K231539pRESET LITE Thrombectomy DevicePOL · Traditional Phenox Limited10/21/2023SE
K222848pRESET Thrombectomy DevicePOL · Traditional Phenox Limited01/20/2023SE
K210502Trevo NXT ProVue RetrieverPOL · Traditional Stryker Neurovascular08/27/2021SE
K203358Solitaire X Revascularization DevicePOL · Traditional Micro Therapeutics, Inc. d/b/a ev3 Neurovascular03/01/2021SE
K203219Trevo XP ProVue Retriever and Trevo NXT™ ProVue RetrieverPOL · Traditional Stryker Neurovascular12/29/2020SE
K193576Solitaire Platinum Revascularization Device, Solitaire X Revascularization Device…POL · Traditional Micro Therapeutics, Inc. d/b/a ev3 Neurovascular11/20/2020SE
K200117Trevo NXT ProVue RetrieverPOL · Special Stryker02/07/2020SE
K192207Trevo NXT ProVue RetrieverPOL · Traditional Stryker11/22/2019SE
K190779Trevo XP ProVue RetrieverPOL · Traditional Stryker06/25/2019SE

More from Stryker

510(k)DeviceDecision
K261889Trevo Trak 21 MicrocatheterQJP · Special 07/01/2026SE
K253032AXS Lift Intracranial Base CatheterQJP · Traditional 02/11/2026SE
K252694Target Detachable CoilHCG · Traditional 12/11/2025SE
K251832InZone IST Detachment System; IZDS Connecting CableHCG · Special 10/17/2025SE
K242289Excelsior XT-27 Microcatheter, Excelsior XT-27 Flex Microcatheter, Excelsior XT-27…QJP · Special 03/21/2025SE
K243593AXS Lift Intracranial Base CatheterQJP · Traditional 02/18/2025SE
K241768Broadway 8 CatheterQJP · Traditional 12/19/2024SE
K241637Echo Intracranial Base CatheterQJP · Traditional 12/19/2024SE
K222533Target Tetra Detachable CoilsHCG · Traditional 12/14/2022SE
K211594Trevo Trak 21 MicrocatheterQJP · Special 11/26/2021SE

Questions and answers

When was Trevo NXT ProVue Retriever cleared by the FDA?

Trevo NXT ProVue Retriever (K223305) received a 510(k) decision of Substantially Equivalent on March 29, 2023, 153 days after the submission was received.

What is the product code of K223305?

The FDA product code is POL – Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment, a Class II (moderate risk) device regulated under 21 CFR 882.5600.